Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cassava Sciences Inc (FLNA) – Cassava Sciences Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

FLNA trades at $1.73, up 2.37% today, but remains in a bearish technical trend with negative profitability metrics. The company reported net losses in recent quarters, though it beat EPS expectations in Q3 and Q4 2025. Cash flow from operations is negative, but financing activities provided a net cash inflow of $7.44M in 2024. Analyst consensus is bullish with 8 buy ratings and no sell recommendations.
The outlook is mixed: strong analyst support contrasts with weak fundamentals and bearish technicals. Investment opportunity hinges on future profitability improvements, while risks include persistent cash burn and high negative ROE/ROA. Stock investors should weigh Wall Street optimism against the company's current financial health challenges.
Read full analysis

Key Stats

  • Market Cap
    $83.57M
  • Sector
    Health
  • 3M Drawdown
    -33.88%
  • Enterprise Value
    -$11.93M
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    33 days
$1.73
52W Low: $1.19
10 Apr 2025
52W High: $4.64
15 Oct 2025

Cassava Sciences Inc (FLNA) is currently valued at a market capitalization of $83.57M, with an enterprise value of -$11.93M. Over the past 52 weeks, Cassava Sciences Inc has traded between a low of $1.19 and a high of $4.64, highlighting its annual price range. Over the past three months, Cassava Sciences Inc has recorded a drawdown of -33.88%, reflecting recent price volatility. Cassava Sciences Inc offers a dividend yield of -. On average, investors hold Cassava Sciences Inc for approximately 33 days, indicating typical investor behavior on the platform.

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease


Technical Indicators
|
|
|
Overall Summary
Bearish (13)Neutral (4)Bullish (10)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $83.57M
  • Sector
    Health
  • 3M Drawdown
    -33.88%
  • Enterprise Value
    -$11.93M
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    33 days
$1.73
52W Low: $1.19
10 Apr 2025
52W High: $4.64
15 Oct 2025

Cassava Sciences Inc (FLNA) is currently valued at a market capitalization of $83.57M, with an enterprise value of -$11.93M. Over the past 52 weeks, Cassava Sciences Inc has traded between a low of $1.19 and a high of $4.64, highlighting its annual price range. Over the past three months, Cassava Sciences Inc has recorded a drawdown of -33.88%, reflecting recent price volatility. Cassava Sciences Inc offers a dividend yield of -. On average, investors hold Cassava Sciences Inc for approximately 33 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!